Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.08
-0.11 (-1.34%)
Jan 29, 2026, 3:15 PM EST - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $141.2 million as of January 29, 2026. Its market cap has increased by 123.58% in one year.
Market Cap
141.20M
Enterprise Value
135.99M
1-Year Change
123.58%
Ranking
Category
Stock Price
$8.08
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $141.20M, a decrease of -54.77%. That is a compound annual growth rate of -25.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 143.12M | 2.89% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 156.01M |
| Unicycive Therapeutics | 154.74M |
| Fate Therapeutics | 151.11M |
| Tenaya Therapeutics | 151.08M |
| Molecular Partners AG | 148.72M |
| Connect Biopharma Holdings | 148.14M |
| Black Diamond Therapeutics | 147.57M |
| Turn Therapeutics | 145.16M |